Nnamdi Njoku was named President of Omnicell, Inc., effective July 1, 2026. As of November 6, 2026, Omnicell, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on July 1, 2026, naming 1 appointment (Form 8-K, July 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like Omnicell, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Omnicell, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-07-01. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as Omnicell, Inc. files it.
Also on the record for Omnicell, Inc.
| Date | Record | Figure | Our page | Source |
|---|---|---|---|---|
| August 10, 2026 | Stake report, Schedule 13G/A, by Millennium Management LLC | 3.8% of the class | 5%+ stakes | Source |
| May 15, 2026 | Stake report, Schedule 13G, by Wellington Management Group LLP | 6% of the class | 5%+ stakes | Source |
| April 30, 2026 | Stake report, Schedule 13G, by Vanguard Capital Management | 5% of the class | 5%+ stakes | Source |
| April 29, 2026 | Stake report, Schedule 13G, by Vanguard Portfolio Management | 7.13% of the class | 5%+ stakes | Source |
| April 1, 2026 | Stake report, Schedule 13G, by Millennium Management LLC | 5% of the class | 5%+ stakes | Source |
| March 27, 2026 | Stake report, Schedule 13G/A, by The Vanguard Group | — | 5%+ stakes | Source |
| October 9, 2025 | Stake report, Schedule 13G, by Dimensional Fund Advisors LP | 5.1% of the class | 5%+ stakes | Source |
Selling to them or working with them? See who runs Omnicell, Inc. now and the warning signs.
Free to see. No signup.
Keep reading
More on Omnicell, Inc. and the records around it.
Omnicell, Inc. elsewhere on the record
- 5%+ stake filings Aug 2026
- Who owns it
Companies that share a holder
- Millennium Management LLC also filed stake reports on 121 other companies: StepStone Group Inc. (Nov 2026), Catalyst Acquisition Corp. (Nov 2026), RxSight, Inc. (Nov 2026)
- Wellington Management Group LLP also filed stake reports on 240 other companies: Hub Group, Inc. (Oct 2026), Latham Group, Inc. (Oct 2026), Redwood Trust, Inc. (Oct 2026)
- Dimensional Fund Advisors LP also filed stake reports on 366 other companies: Acadia Healthcare Co Inc (Oct 2026), ADT Inc (Oct 2026), AGCO Corp (Oct 2026)
Watch Omnicell, Inc.
Get an email when Omnicell, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Omnicell, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Omnicell, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Omnicell, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
8 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-07-01 | In | President | 2026-07-01 | 8-K, 2026-07-01 |
Who leads Omnicell, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President: Nnamdi Njoku, appointed, effective 2026-07-01 (filed 2026-07-01).
New leaders reset buying decisions — get the Full Report on Omnicell, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President at Omnicell, Inc., with the record behind each one.
Find candidates like President at Omnicell, Inc.Every change, in the filing's words
Appointed: Nnamdi Njoku, President, effective 2026-07-01
On June 30, 2026, the Board of Directors ("Board") of Omnicell, Inc. ("Omnicell" or the "Company") appointed Mr. Nnamdi Njoku to serve as President of the Company, effective July 1, 2026.
- Mr. Njoku will retain his role of Chief Operating Officer of the Company.
- In his role as President and Chief Operating Officer, Mr. Njoku will shape and advance Omnicell's long-term growth strategy and innovation roadmap, focused on scaling global operations while seeking to ensure seamless operational execution and excellence across product, innovation, and customer experience.
- In connection with Mr. Njoku's promotion, the Company's President, Chief Executive Officer and Chairman of the Board, Randall A. Lipps, stepped down from his role as President of the Company.
- Mr. Lipps will continue to serve as Chief Executive Officer and Chairman of the Board, and there will be no compensation changes in connection with Mr. Lipps' transitioning President duties to Mr. Njoku.
- Mr. Njoku will continue to report to Mr. Lipps.
- Before being appointed as President and Chief Operating Officer of Omnicell, Mr. Njoku, age 49, served as Executive Vice President and Chief Operating Officer of the Company from October 2024 until June 2026.
- Prior to joining Omnicell, Mr. Njoku served as President - Sports Medicine, Surgical, Upper Extremities and Restorative Therapies of Zimmer Biomet Holdings, Inc., a global medical technology leader, from March 2023 to September 2024.
Tools for this story
Each opens in a new tab, filled in for Omnicell, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.